Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Paclitaxel Polymeric Micelles, Cisplatin, and Sintilimab as Neoadjuvant Therapy for ESCC
NCT07799077Phase 2Not yet recruiting
- Sponsor
- The Fourth Hospital of Hebei Medical University
- Start
- Sep 2026
- Primary completion
- Dec 2027
- Countries
- 1
01
Overview
A Phase 2 trial of Paclitaxel Micelles for Injection in Esophageal Squamous Cell Carcinoma (ESCC), sponsored by The Fourth Hospital of Hebei Medical University. Planned start Sep 2026; status: not yet recruiting.
02
Drugs
Paclitaxel Micelles for Injection
03
Conditions
Esophageal Squamous Cell Carcinoma (ESCC)
Beyond the preview
Go deeper on NCT07799077.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07799077.